Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment
Authors
Keywords
Pharmacogenetics, Pharmacoepigenetics, Antipsychotic, Treatment response, Schizophrenia
Journal
SCHIZOPHRENIA RESEARCH
Volume 232, Issue -, Pages 112-124
Publisher
Elsevier BV
Online
2021-05-26
DOI
10.1016/j.schres.2021.05.010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia
- (2021) Eilis Hannon et al. eLife
- Integrative Genomic–Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis
- (2021) Yerye Gibrán Mayén-Lobo et al. Pharmaceuticals
- A risk prediction model of DNA methylation improves prognosis evaluation and indicates gene targets in prostate cancer
- (2020) Enchong Zhang et al. Epigenomics
- Variants of GRM7 as risk factor and response to antipsychotic therapy in schizophrenia
- (2020) Wei Liang et al. Translational Psychiatry
- Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients
- (2020) Elisabetta Maffioletti et al. DRUG DEVELOPMENT RESEARCH
- Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients
- (2019) Wei Zhou et al. Frontiers in Pharmacology
- Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
- (2019) John F. Greden et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Association of Serotonin2c Receptor Polymorphisms With Antipsychotic Drug Response in Schizophrenia
- (2019) Jiang Li et al. Frontiers in Psychiatry
- Methodological challenges in constructing DNA methylation risk scores
- (2019) Anke Hüls et al. Epigenetics
- Association Study of KCNH7 Polymorphisms and Individual Responses to Risperidone Treatment in Schizophrenia
- (2019) Xueping Wang et al. Frontiers in Psychiatry
- Pharmacogenetic Tests in Psychiatry
- (2018) Chad Bousman et al. AMERICAN JOURNAL OF PSYCHIATRY
- New findings in pharmacogenetics of schizophrenia
- (2018) Clement C. Zai et al. CURRENT OPINION IN PSYCHIATRY
- The functional genomics laboratory: functional validation of genetic variants
- (2018) Richard J. Rodenburg JOURNAL OF INHERITED METABOLIC DISEASE
- Impact of antipsychotic treatment on methylation status of Interleukin-6 [IL-6] gene in Schizophrenia
- (2018) Deepthi Venugopal et al. JOURNAL OF PSYCHIATRIC RESEARCH
- DNA methylation of ANKK1 and response to aripiprazole in patients with acute schizophrenia: A preliminary study
- (2018) Itaru Miura et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Combinatorial pharmacogenomics and improved patient outcomes in depression: Treatment by primary care physicians or psychiatrists
- (2018) Julie-Anne Tanner et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection
- (2018) Antonio F. Pardiñas et al. NATURE GENETICS
- DNA methylation-based biomarkers and the epigenetic clock theory of ageing
- (2018) Steve Horvath et al. NATURE REVIEWS GENETICS
- DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations
- (2018) Amanda J. Lisoway et al. NEUROSCIENCE LETTERS
- Gene–gene interaction between DRD4 and COMT modulates clinical response to clozapine in treatment-resistant schizophrenia
- (2018) Veera M. Rajagopal et al. Pharmacogenetics and Genomics
- DNA methylation and antipsychotic treatment mechanisms in schizophrenia: Progress and future directions
- (2018) Ellen S. Ovenden et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials
- (2018) Chiara Fabbri et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication
- (2018) Lucas M. Walden et al. PSYCHIATRY RESEARCH
- Understanding the influence of antipsychotic drugs on global methylation events and its relevance in treatment response
- (2018) Babu Swathy et al. Epigenomics
- Cytosine modifications exhibit circadian oscillations that are involved in epigenetic diversity and aging
- (2018) Gabriel Oh et al. Nature Communications
- The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis
- (2018) Joshua D. Rosenblat et al. JOURNAL OF AFFECTIVE DISORDERS
- Methylome-wide association findings for major depressive disorder overlap in blood and brain and replicate in independent brain samples
- (2018) Karolina A. Aberg et al. MOLECULAR PSYCHIATRY
- Pharmacogenetics analysis of serotonin receptor gene variants and clinical response to risperidone in Han Chinese schizophrenic patients
- (2018) Wei Zhou et al. NEUROSCIENCE LETTERS
- Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
- (2018) Marcos Leite Santoro et al. Translational Psychiatry
- Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis
- (2018) Jian-Ping Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Dopamine (DRD2 ) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia
- (2018) Charanraj Goud Alladi et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder
- (2018) Charanraj Goud Alladi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prediction of Schizophrenia Diagnosis by Integration of Genetically Correlated Conditions and Traits
- (2018) Jingchun Chen et al. Journal of Neuroimmune Pharmacology
- Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials
- (2018) Chad A Bousman et al. PHARMACOGENOMICS
- Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia
- (2017) Makoto Kinoshita et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Cost of Relapse in Schizophrenia
- (2017) Mark Pennington et al. PHARMACOECONOMICS
- DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients
- (2017) Abd Rahim Nour El Huda et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia
- (2017) Theresa Wimberley et al. SCHIZOPHRENIA BULLETIN
- BECon: a tool for interpreting DNA methylation findings from blood in the context of brain
- (2017) R D Edgar et al. Translational Psychiatry
- Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients
- (2017) Y Shi et al. Translational Psychiatry
- Is an Early Age at Illness Onset in Schizophrenia Associated With Increased Genetic Susceptibility? Analysis of Data From the Nationwide Danish Twin Register
- (2017) Rikke Hilker et al. EBioMedicine
- Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes
- (2017) Jiang Li et al. SCHIZOPHRENIA RESEARCH
- Pharmacogenetics of clozapine response and induced weight gain: A comprehensive review and meta-analysis
- (2016) Florence Gressier et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
- (2016) Kelly E. Caudle et al. GENETICS IN MEDICINE
- Genetic association analysis of N-methyl-d-aspartate receptor subunit geneGRIN2Band clinical response to clozapine
- (2016) Danielle L. Taylor et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis
- (2016) Eric Huang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The Economic Burden of Schizophrenia in the United States in 2013
- (2016) Martin Cloutier et al. JOURNAL OF CLINICAL PSYCHIATRY
- Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response
- (2016) Eric Huang et al. PHARMACOGENOMICS
- Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study
- (2016) Carolina Montano et al. JAMA Psychiatry
- Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes
- (2016) J M Stevenson et al. Translational Psychiatry
- Improving Phenotypic Prediction by Combining Genetic and Epigenetic Associations
- (2015) Sonia Shah et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Antipsychotic drugs attenuate aberrant DNA methylation ofDTNBP1(dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder
- (2015) Hamid M. Abdolmaleky et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality
- (2015) David M. Evans et al. Annual Review of Genomics and Human Genetics
- DNA Modification Study of Major Depressive Disorder: Beyond Locus-by-Locus Comparisons
- (2015) Gabriel Oh et al. BIOLOGICAL PSYCHIATRY
- Antipsychotic medication in schizophrenia: a review
- (2015) John Lally et al. BRITISH MEDICAL BULLETIN
- Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication
- (2015) Xiaojing Tang et al. CURRENT DRUG METABOLISM
- Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update
- (2015) Venuja Sriretnakumar et al. Expert Opinion on Drug Metabolism & Toxicology
- Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex
- (2015) Andrew E Jaffe et al. NATURE NEUROSCIENCE
- Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics
- (2015) Giuseppe Blasi et al. NEUROPSYCHOPHARMACOLOGY
- Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology
- (2015) Leonel E. Rojo et al. PHARMACOLOGICAL RESEARCH
- Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response
- (2015) Luiza P.R. de Matos et al. PSYCHIATRY RESEARCH
- Association of a Schizophrenia Risk Variant at theDRD2Locus With Antipsychotic Treatment Response in First-Episode Psychosis
- (2015) Jian-Ping Zhang et al. SCHIZOPHRENIA BULLETIN
- Cytochrome P450 genotypes are not associated with refractoriness to antipsychotic treatment
- (2015) M.T. van de Bilt et al. SCHIZOPHRENIA RESEARCH
- Differences in the Epigenetic Regulation of Cytochrome P450 Genes between Human Embryonic Stem Cell-Derived Hepatocytes and Primary Hepatocytes
- (2015) Han-Jin Park et al. PLoS One
- DNA extracted from saliva for methylation studies of psychiatric traits: Evidence tissue specificity and relatedness to brain
- (2014) Alicia K. Smith et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- PRSice: Polygenic Risk Score software
- (2014) Jack Euesden et al. BIOINFORMATICS
- Whole genome methylation analyses of schizophrenia patients before and after treatment
- (2014) Blaga Rukova et al. BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
- Accounting for Population Stratification in DNA Methylation Studies
- (2014) Richard T. Barfield et al. GENETIC EPIDEMIOLOGY
- Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients
- (2014) J Frank et al. MOLECULAR PSYCHIATRY
- Analytical tools and current challenges in the modern era of neuroepigenomics
- (2014) Ian Maze et al. NATURE NEUROSCIENCE
- Identification of Candidate Single-Nucleotide Polymorphisms in NRXN1 Related to Antipsychotic Treatment Response in Patients with Schizophrenia
- (2014) Aaron Jenkins et al. NEUROPSYCHOPHARMACOLOGY
- Replication of SULT4A1-1 as a pharmacogenetic marker of olanzapine response and evidence of lower weight gain in the high response group
- (2014) Timothy L Ramsey et al. PHARMACOGENOMICS
- Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients
- (2014) Matea Nikolac Perkovic et al. PSYCHOPHARMACOLOGY
- Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia
- (2014) Jeffrey R. Bishop et al. PSYCHOPHARMACOLOGY
- Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial
- (2014) Timothy L. Ramsey et al. SCHIZOPHRENIA RESEARCH
- Buccals are likely to be a more informative surrogate tissue than blood for epigenome-wide association studies
- (2013) Robert Lowe et al. Epigenetics
- The social and economic burden of treatment-resistant schizophrenia
- (2013) James L. Kennedy et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Methylation at a transcription factor-binding site on the 5-HT1A receptor gene correlates with negative symptom treatment response in first episode schizophrenia
- (2013) Hao Tang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis
- (2013) A K Tiwari et al. MOLECULAR PSYCHIATRY
- DNA methylation analysis of BDNF gene promoters in peripheral blood cells of schizophrenia patients
- (2013) Tempei Ikegame et al. NEUROSCIENCE RESEARCH
- Remission in Schizophrenia: Critical and Systematic Review
- (2013) Bandar AlAqeel et al. HARVARD REVIEW OF PSYCHIATRY
- Using summary data from the Danish National Registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder
- (2013) Naomi Wray Frontiers in Genetics
- Base-Resolution Analyses of Sequence and Parent-of-Origin Dependent DNA Methylation in the Mouse Genome
- (2012) Wei Xie et al. CELL
- Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset
- (2012) Philippe A. Melas et al. FASEB JOURNAL
- Commentary: The seven plagues of epigenetic epidemiology
- (2012) Bastiaan T Heijmans et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- DNA methylation profiling in the clinic: applications and challenges
- (2012) Holger Heyn et al. NATURE REVIEWS GENETICS
- Analysing and interpreting DNA methylation data
- (2012) Christoph Bock NATURE REVIEWS GENETICS
- Epigenetic Studies of Schizophrenia: Progress, Predicaments, and Promises for the Future
- (2012) Emma Dempster et al. SCHIZOPHRENIA BULLETIN
- Epigenetics of major psychosis: progress, problems and perspectives
- (2012) Viviane Labrie et al. TRENDS IN GENETICS
- Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder
- (2011) Mohammad Ghadirivasfi et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder
- (2011) Emma L. Dempster et al. HUMAN MOLECULAR GENETICS
- An Algorithm-Based Approach to First-Episode Schizophrenia
- (2011) Ofer Agid et al. JOURNAL OF CLINICAL PSYCHIATRY
- Plk5, a Polo Box Domain-Only Protein with Specific Roles in Neuron Differentiation and Glioblastoma Suppression
- (2011) G. de Carcer et al. MOLECULAR AND CELLULAR BIOLOGY
- Pharmacogenetics in psychiatry: translating research into clinical practice
- (2011) A K Malhotra et al. MOLECULAR PSYCHIATRY
- Familial occurrence of tardive dyskinesia
- (2010) D. J. Müller et al. ACTA PSYCHIATRICA SCANDINAVICA
- Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
- (2010) Richard Mailman et al. CURRENT PHARMACEUTICAL DESIGN
- Tissue specific DNA methylation of CpG islands in normal human adult somatic tissues distinguishes neural from non-neural tissues
- (2010) Srimoyee Ghosh et al. Epigenetics
- Epigenetics as a unifying principle in the aetiology of complex traits and diseases
- (2010) Arturas Petronis NATURE
- The Path to Personalized Medicine
- (2010) Margaret A. Hamburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Classical twin design in modern pharmacogenomics studies
- (2010) Nilüfer Rahmioğlu et al. PHARMACOGENOMICS
- Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
- (2009) Shaun M. Purcell et al. NATURE
- HES1 regulates 5-HT1A receptor gene transcription at a functional polymorphism: Essential role in developmental expression
- (2008) Kirsten X. Jacobsen et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- DNA methylation landscapes: provocative insights from epigenomics
- (2008) Miho M. Suzuki et al. NATURE REVIEWS GENETICS
- Calcium Channel Regulation and Presynaptic Plasticity
- (2008) William A. Catterall et al. NEURON
- Epigenetics and Complex Disease: From Etiology to New Therapeutics
- (2007) Carolyn Ptak et al. Annual Review of Pharmacology and Toxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now